Frequently Asked Questions
The market is segmented based on Segmentation, By Product and Services (Instruments and Devices, Assays and Reagents, Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis, Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales, Other) – Industry Trends and Forecast to 2031
.
The Global Respiratory Diagnostics Market size was valued at USD 8.69 USD Billion in 2023.
The Global Respiratory Diagnostics Market is projected to grow at a CAGR of 8% during the forecast period of 2024 to 2031.
The major players operating in the market include GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Medtronic, COSMED srl, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, Drägerwerk AG & Co. KGaA, Bio-Rad Laboratories , GC Diagnostics Corporation, Masimo, bioMérieux SA, Carestream Health, Thermo Fisher Scientific , Novartis AG, Abbott, Johnson & Johnson Services , GlaxoSmithKline plc, Bayer AG, BD,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
